Literature DB >> 9806552

Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue.

D Lauro1, Y Kido, A L Castle, M J Zarnowski, H Hayashi, Y Ebina, D Accili.   

Abstract

Type 2 diabetes is a complex metabolic disorder characterized by peripheral insulin resistance and impaired beta cell function. Insulin resistance is inherited as a non-mendelian trait. In genetically predisposed individuals, resistance of skeletal muscle and adipose tissue to insulin action precedes the onset of clinical diabetes, and is thought to contribute to hyperglycaemia by leading to impaired beta cell function and increased hepatic glucose production. It is not clear whether beta cell and liver defects are also genetically determined. To test the hypothesis that insulin resistance in muscle and fat is sufficient to cause type 2 diabetes in the absence of intrinsic beta cell and liver abnormality, we generated transgenic mice that were insulin-resistant in skeletal muscle and adipose tissue. These mice developed all the prodromal features of type 2 diabetes but, despite the compounded effect of peripheral insulin resistance and a mild impairment of beta cell function, failed to become diabetic. These findings indicate the need for a critical re-examination of the primary site(s) of insulin resistance in diabetes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806552     DOI: 10.1038/3112

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  33 in total

1.  Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR.

Authors:  J Nakae; V Barr; D Accili
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

2.  Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice.

Authors:  O Gavrilova; B Marcus-Samuels; D Graham; J K Kim; G I Shulman; A L Castle; C Vinson; M Eckhaus; M L Reitman
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

Review 3.  Tissue-specific targeting of the insulin receptor gene.

Authors:  Rohit N Kulkarni; Terumasa Okada
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

4.  Transgenic rescue of insulin receptor-deficient mice.

Authors:  Haruka Okamoto; Jun Nakae; Tadahiro Kitamura; Byung-Chul Park; Ioannis Dragatsis; Domenico Accili
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 5.  New insights into the integrated physiology of insulin action.

Authors:  Yukari Kitamura; Domenico Accili
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

6.  Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action.

Authors:  Haruka Okamoto; Silvana Obici; Domenico Accili; Luciano Rossetti
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

7.  Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.

Authors:  Y Kido; D J Burks; D Withers; J C Bruning; C R Kahn; M F White; D Accili
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

8.  Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance.

Authors:  J M Zabolotny; Y B Kim; O D Peroni; J K Kim; M A Pani; O Boss; L D Klaman; S Kamatkar; G I Shulman; B B Kahn; B G Neel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

Review 9.  Novel roles for insulin receptor (IR) in adipocytes and skeletal muscle cells via new and unexpected substrates.

Authors:  Latha Ramalingam; Eunjin Oh; Debbie C Thurmond
Journal:  Cell Mol Life Sci       Date:  2012-10-10       Impact factor: 9.261

10.  Junctional communication of pancreatic beta cells contributes to the control of insulin secretion and glucose tolerance.

Authors:  A Charollais; A Gjinovci; J Huarte; J Bauquis; A Nadal; F Martín; E Andreu; J V Sánchez-Andrés; A Calabrese; D Bosco; B Soria; C B Wollheim; P L Herrera; P Meda
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.